According to Astellas Pharma's latest financial reports the company's current earnings (TTM) are C$0.21 B. In 2023 the company made an earning of C$0.16 B a decrease over its 2022 earnings that were of C$1.65 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.